New Delhi: With 24,337 new infections India's COVID-19 caseload rose to 1,00,55,560, while the number of people who have recuperated from the disease crossed 96 lakh, according to Union health ministry data updated on Monday.
The death toll increased to 1,45,810 with 333 new fatalities, the data updated at 8 am showed.
The number of people who have recuperated from the disease surged to 96,06,111, pushing the national recovery rate to 95.53 per cent, while the COVID-19 case fatality rate stands at 1.45 per cent, according to the data.
India sees 24,337 new #COVID19 cases, 333 deaths in last 24 hours. 25709 Covid patients recovered during the period: Health Ministry.
Total cases: 1,00,55,560
Total recoveries: 96,06,111
Active cases: 3,03,639
Death toll: 1,45,810 pic.twitter.com/Xl0j1CBtvN
— OTV (@otvnews) December 21, 2020
The COVID-19 active caseload remained below 4 lakh for the 15th consecutive day.
There are 3,03,639 active coronavirus cases in the country which comprise 3.02 per cent of the total caseload, the data stated.
India's COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16.
It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one-crore mark on December 19.
According to the Indian Council of Medical Research (ICMR), 16,20,98,329 samples have been tested up to December 20 with 9,00,134 samples being tested on Sunday.
Maharashtra continues to be the worst-hit state with 18,96,518 cases till date.
Over 70 per cent of the daily new cases are being reported by 10 states and union territory -- Kerala, Maharashtra, West Bengal, Chhattisgarh, Uttar Pradesh, Karnataka, Delhi, Tamil Nadu, Gujarat and Madhya Pradesh.
Over 75 per cent of the deaths are being reported from Maharashtra, West Bengal, Delhi, Kerala, Uttar Pradesh, Punjab, Karnataka, Madhya Pradesh, Tamil Nadu and Haryana.
There is, however, light at the end of the tunnel as India has eight Covid-19 vaccine candidates, including three indigenous vaccines, under different stages of clinical trials which could be ready for authorisation in near future.
It includes AstraZeneca and Oxford university developed and Serum Institute of India manufactured Covishield, Covaxin by Bharat Biotech Limited, ZyCoV-D by Zydus Cadila and Russian vaccine candidate Sputnik-V.
The list also contains NVX-CoV2373 by SII, HGCO19 by Geneva, and two unlabeled vaccines-Recombinant Protein Antigen based vaccine by Biological E Limited-and Inactivated rabies vector platform by Bharat Biotech.
(With Agency Inputs)